Old Web
English
Sign In
Acemap
>
Paper
>
Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma.
Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma.
2020
Matteo Costacurta
Stephin J. Vervoort
Simon J. Hogg
Benjamin P. Martin
Ricky W. Johnstone
Jake Shortt
Keywords:
Computational biology
Sensitization
Multiple myeloma
CRISPR
Biology
Genome
Correction
Source
Cite
Save
Machine Reading By IdeaReader
15
References
2
Citations
NaN
KQI
[]